Exystat   Report issue

For profit Phase 3 Phase 4
Founded: Malakoff France (2013)

Organization Overview

First Clinical Trial
2013
NCT03362684
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Exystat

Active Ingredients

Drugs in Phase 4 Trials (1)

methoxyflurane (penthrane) (1 trial)

Drugs in Phase 3 Trials (4)

cetuximab (erbitux) (1 trial)

fluorouracil (efudex) (1 trial)

leucovorin (1 trial)

oxaliplatin (eloxatin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Pain (Phase 4)

Colorectal Neoplasms (Phase 3)

Emergencies (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 5